Javier Cortes, MD
IOB and VHIO; Spain · Hospital Universitario Ramon y Cajal · Hospital Universitario Vall d'Hebrón, Spain
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Javier Cortes, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:54 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03786094 · Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast CancerSpexis AG · terminated · Metastatic Breast Cancer, Locally Recurrent Breast Cancer · principal investigator
- Ph2NCT03184090 · Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBCMedSIR · completed · Metastatic Breast Cancer · principal investigator
- Ph2NCT02053636 · A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast CancerInstitut de Recherches Internationales Servier · completed · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.